Related Experiment Video
Updated: May 20, 2025

09:20
Simultaneous Measurement of HDAC1 and HDAC6 Activity in HeLa Cells Using UHPLC-MS
Published on: August 10, 2017
8.5K
Cell-based determination of HDAC10-mediated polyamine deacetylase activity
Ishika Gupta1, Ashley Nwafor1, Robert A Casero1
1Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins School of Medicine, Baltimore, MD, United States.
Methods in Enzymology
|May 17, 2025
Summary
Histone deacetylase 10 (HDAC10) uniquely processes N8-acetylspermidine, aiding polyamine homeostasis. New cell-based assays quantify this polyamine deacetylase (PDAC) activity for research and drug screening.
Area of Science:
- Biochemistry
- Molecular Biology
- Enzymology
Background:
- Histone deacetylases (HDACs) are crucial enzymes involved in epigenetic regulation.
- HDAC10 exhibits a unique substrate specificity for acetylated polyamines, particularly N8-acetylspermidine (N8-AcSpd).
- N8-AcSpd is an extracellular metabolite produced by certain intestinal microbes, influencing cellular polyamine levels.
Purpose of the Study:
- To detail methodologies for quantifying HDAC10-mediated polyamine deacetylase (PDAC) activity.
- To establish cell-based assays for assessing tissue-specific PDAC activity.
- To provide a foundation for high-throughput screening of HDAC10 modulators.
Main Methods:
- Development of cell-based assays to measure relative levels of HDAC10-mediated PDAC activity.
- Utilizing N8-AcSpd as a specific substrate for HDAC10.
- Cost-efficient experimental design for broad applicability.
Main Results:
- HDAC10's role as a specific polyamine deacetylase is confirmed.
- The assays allow for the determination of tissue-specific differences in PDAC activity.
- The methods are adaptable for screening potential HDAC inhibitors.
Conclusions:
- HDAC10 plays a key role in polyamine homeostasis through its unique deacetylase activity.
- Quantifying PDAC activity is essential for understanding tissue-specific polyamine metabolism.
- The developed assays offer a valuable tool for pharmacological research targeting HDAC10.

